136 related articles for article (PubMed ID: 35916591)
1. Lethal Acute Colonic Pseudo-Obstruction in a Patient Using a Combination of Olanzapine and Clozapine.
Bouhuis RH; van Verschuer VMT; Zaal RJ; Dieleman S
J Clin Psychopharmacol; 2022 Sep-Oct 01; 42(5):511-513. PubMed ID: 35916591
[No Abstract] [Full Text] [Related]
2. Clozapine- and Olanzapine-induced oesophagitis and haematemesis: A case report.
Chau E; Jagadheesan K
Aust N Z J Psychiatry; 2021 Dec; 55(12):1211. PubMed ID: 33951961
[No Abstract] [Full Text] [Related]
3. [Chronic colonic pseudo-obstruction secondary to neuroleptics].
Benlloch S; Pérez-Aguilar F; Ponce J; Berenguer J
Gastroenterol Hepatol; 2001 Dec; 24(10):500-2. PubMed ID: 11730619
[TBL] [Abstract][Full Text] [Related]
4. [Hematological alterations associated to olanzapine use after clozapine-induced neutropenia].
Cabral CG; de Castro M; das Neves L; Nicolato R; Lauar H; Salgado JV
Braz J Psychiatry; 2007 Mar; 29(1):93. PubMed ID: 17435944
[No Abstract] [Full Text] [Related]
5. [Ogilvie Syndrome induced by clozapine].
de Bruin GJ; Bac DJ; van Puijenbroek EP; van der Klooster JM
Ned Tijdschr Geneeskd; 2009; 153():B437. PubMed ID: 20051163
[TBL] [Abstract][Full Text] [Related]
6. Prolongation of clozapine-induced leukopenia with olanzapine treatment.
Sayin A; Cosar B
Prog Neuropsychopharmacol Biol Psychiatry; 2006 Jul; 30(5):958-9. PubMed ID: 16631295
[TBL] [Abstract][Full Text] [Related]
7. Developed catatonia with rhabdomyolysis and exacerbated cardiac failure upon switching from clozapine to olanzapine owing to cardiomyopathy during clozapine medication - A case report.
Ito Y; Murata M; Taku O; Fukuyama K; Motomura E; Dohi K; Okada M
Asian J Psychiatr; 2023 Feb; 80():103376. PubMed ID: 36493522
[No Abstract] [Full Text] [Related]
8. [Treatment-resistant schizophrenia: Neutropenia with olanzapine and clozapine, and stabilization with two depot antipsychotics].
Alba P
Vertex; 2017 Mar; 28(132):141-144. PubMed ID: 29522636
[TBL] [Abstract][Full Text] [Related]
9. Clozapine related Ogilvie syndrome with fatal outcome.
Akkaş M; Demir MC
Riv Psichiatr; 2020; 55(1):53-56. PubMed ID: 32051627
[TBL] [Abstract][Full Text] [Related]
10. Clozapine and Ogilvie syndrome in Schizophrenia: Case report of a successful rechallenge.
Philip S; Jose A; Silvester L; Shekhar A; George G; Sudha MD; Najeeb S
Asian J Psychiatr; 2022 Nov; 77():103249. PubMed ID: 36095882
[No Abstract] [Full Text] [Related]
11. Prolongation of clozapine-induced neutropenia with olanzapine.
Jagadheesan K; Mehrtens J
Aust N Z J Psychiatry; 2007 Feb; 41(2):192. PubMed ID: 17464699
[No Abstract] [Full Text] [Related]
12. A case of late-onset angioedema associated with clozapine and redevelopment of angioedema with olanzapine.
Tatar ZB; Oflaz S; Baran B
J Clin Psychopharmacol; 2014 Aug; 34(4):523-5. PubMed ID: 24911442
[No Abstract] [Full Text] [Related]
13. [Acute hepatocellular lesion after successive exposure to clozapine and olanzapine in a patient with chronic hepatitis C infection].
Gómez Espín R; Sánchez Quiles I; Hallal H; Plaza J
Gastroenterol Hepatol; 2010 Feb; 33(2):150-2. PubMed ID: 19914745
[No Abstract] [Full Text] [Related]
14. Quetiapine, clozapine, and olanzapine in the treatment of tardive dyskinesia induced by first-generation antipsychotics: a 124-week case report.
Sacchetti E; Valsecchi P
Int Clin Psychopharmacol; 2003 Nov; 18(6):357-9. PubMed ID: 14571157
[TBL] [Abstract][Full Text] [Related]
15. Successful re-exposure to clozapine following uneventful rechallenge with olanzapine in a patient with neutropenia related to both agents.
Wu SY; Liu CC; Hsieh MH
Prog Neuropsychopharmacol Biol Psychiatry; 2008 May; 32(4):1089-90. PubMed ID: 18407390
[No Abstract] [Full Text] [Related]
16. A comparison of incidence of diabetes mellitus between atypical antipsychotic drugs: a survey for clozapine, risperidone, olanzapine, and quetiapine.
Sumiyoshi T; Roy A; Anil AE; Jayathilake K; Ertugrul A; Meltzer HY
J Clin Psychopharmacol; 2004 Jun; 24(3):345-8. PubMed ID: 15118492
[No Abstract] [Full Text] [Related]
17. Weight gain in children and adolescents during 45 weeks treatment with clozapine, olanzapine and risperidone.
Fleischhaker C; Heiser P; Hennighausen K; Herpertz-Dahlmann B; Holtkamp K; Mehler-Wex C; Rauh R; Remschmidt H; Schulz E; Warnke A
J Neural Transm (Vienna); 2008 Nov; 115(11):1599-608. PubMed ID: 18779922
[TBL] [Abstract][Full Text] [Related]
18. Impact of tobacco smoking cessation on stable clozapine or olanzapine treatment.
Lowe EJ; Ackman ML
Ann Pharmacother; 2010 Apr; 44(4):727-32. PubMed ID: 20233914
[TBL] [Abstract][Full Text] [Related]
19. Placebo-controlled trial of atomoxetine for weight reduction in people with schizophrenia treated with clozapine or olanzapine.
Ball MP; Warren KR; Feldman S; McMahon RP; Kelly DL; Buchanan RW
Clin Schizophr Relat Psychoses; 2011 Apr; 5(1):17-25. PubMed ID: 21459735
[TBL] [Abstract][Full Text] [Related]
20. Prolongation of clozapine-induced granulocytopenia associated with olanzapine.
Flynn SW; Altman S; MacEwan GW; Black LL; Greenidge LL; Honer WG
J Clin Psychopharmacol; 1997 Dec; 17(6):494-5. PubMed ID: 9408818
[No Abstract] [Full Text] [Related]
[Next] [New Search]
